FAAH and social phobia: Our findings provide support to recent, preliminary findings from a clinical trial in social anxiety disorder, which suggests that a 12-week daily regimen of the FAAH inhibitor JNJ-42165279 nominally improves scores on the Liebowitz Social Anxiety Scale as well as the Clinical Global Impression-Improvement scale (Schmidt et al., 2020).